Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma.

Chung GT, Lung RW, Hui AB, Yip KY, Woo JK, Chow C, Tong CY, Lee SD, Yuen JW, Lun SW, Tso KK, Wong N, Tsao SW, Yip TT, Busson P, Kim H, Seo JS, O'Sullivan B, Liu FF, To KF, Lo KW.

J Pathol. 2013 Oct;231(2):158-67. doi: 10.1002/path.4240.

2.

MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.

Cheung CC, Lun SW, Chung GT, Chow C, Lo C, Choy KW, Lo KW.

BMC Cancer. 2016 Jul 19;16:495. doi: 10.1186/s12885-016-2525-5.

3.

Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.

Man CH, Wei-Man Lun S, Wai-Ying Hui J, To KF, Choy KW, Wing-Hung Chan A, Chow C, Tin-Yun Chung G, Tsao SW, Tak-Chun Yip T, Busson P, Lo KW.

J Pathol. 2012 Feb;226(3):471-81. doi: 10.1002/path.2997. Epub 2011 Oct 19.

PMID:
22009689
4.

Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.

Chung GT, Lou WP, Chow C, To KF, Choy KW, Leung AW, Tong CY, Yuen JW, Ko CW, Yip TT, Busson P, Lo KW.

J Pathol. 2013 Nov;231(3):311-22. doi: 10.1002/path.4239. Epub 2013 Sep 3.

PMID:
23868181
5.

Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Chiu SH, Wu CC, Fang CY, Yu SL, Hsu HY, Chow YH, Chen JY.

Oncotarget. 2014 Sep 30;5(18):8583-601.

7.

Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies.

Decaussin G, Sbih-Lammali F, de Turenne-Tessier M, Bouguermouh A, Ooka T.

Cancer Res. 2000 Oct 1;60(19):5584-8.

8.

The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma.

Hsu CY, Yi YH, Chang KP, Chang YS, Chen SJ, Chen HC.

PLoS Pathog. 2014 Feb 27;10(2):e1003974. doi: 10.1371/journal.ppat.1003974. eCollection 2014 Feb.

9.

Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis.

Friboulet L, Pioche-Durieu C, Rodriguez S, Valent A, Souquère S, Ripoche H, Khabir A, Tsao SW, Bosq J, Lo KW, Busson P.

Neoplasia. 2008 Nov;10(11):1183-94.

10.

STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.

Lui VW, Wong EY, Ho Y, Hong B, Wong SC, Tao Q, Choi GC, Au TC, Ho K, Yau DM, Ma BB, Hui EP, Chan AS, Tsang CM, Tsao SW, Grandis JR, Chan AT.

Int J Cancer. 2009 Oct 15;125(8):1884-93. doi: 10.1002/ijc.24567.

11.
12.

Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.

Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY.

Cancer. 2012 Feb 1;118(3):698-710. doi: 10.1002/cncr.26309. Epub 2011 Jun 30.

13.

Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.

Hui KF, Ho DN, Tsang CM, Middeldorp JM, Tsao GS, Chiang AK.

Int J Cancer. 2012 Oct 15;131(8):1930-40. doi: 10.1002/ijc.27439. Epub 2012 Mar 8.

14.

Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems.

Szeto CY, Lin CH, Choi SC, Yip TT, Ngan RK, Tsao GS, Li Lung M.

FEBS Open Bio. 2014 Jan 13;4:128-40. doi: 10.1016/j.fob.2014.01.004. eCollection 2014.

15.

Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.

Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, Xiao L, Huang D, Li Z, Li D, Wu M, Li X, Shen S, Wang R, Cao L, Tang K, Li G.

Acta Biochim Biophys Sin (Shanghai). 2009 May;41(5):414-28.

16.

Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.

Xu M, Cheung CC, Chow C, Lun SW, Cheung ST, Lo KW.

PLoS One. 2016 Jun 3;11(6):e0156833. doi: 10.1371/journal.pone.0156833. eCollection 2016.

17.

Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.

Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, Chen QY, Zhang X, Li MZ, Shao JY, Qian CN, Xia YF, Song LB, Zeng YX, Zeng MS.

PLoS Pathog. 2010 Jun 3;6(6):e1000940. doi: 10.1371/journal.ppat.1000940.

18.

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.

Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC.

Int J Cancer. 1999 Sep 24;83(1):121-6.

19.

Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.

Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Paramita DK, Fachiroh J, Adham M, Tan IB, Haryana SM, Middeldorp JM.

Int J Cancer. 2006 Aug 1;119(3):608-14.

20.

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.

Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX.

Cancer Biol Ther. 2007 Dec;6(12):1997-2004. Epub 2007 Oct 13.

PMID:
18087217

Supplemental Content

Support Center